Skip to main content
Caplight Logo









EMFRET Analytics GmbH & Co. KG

EMFRET Analytics GmbH & Co. KG

Private
EibelstadtHealthcare & Life Scienceshttps://www.emfret.com/

Last Round

Corporate Funding

Mar 30, 2026

Company Overview

EMFRET Analytics GmbH & Co. KG is a biotechnology company that specializes in the production, characterization, and supply of monoclonal antibodies for biomedical research and the development of therapeutic candidates for cardiovascular and thrombo-inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibodiesvascular biologyplatelet researchresearch reagentsthrombosis researchhemostasis researchflow cytometryin vivo imagingimmunoassaytherapeutic developmentmurine modelspreclinical researchbiotech lab suppliesantibody discoverythrombo-inflammation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EMFRET Analytics GmbH & Co. KG Comparables

Compare EMFRET Analytics GmbH & Co. KG with similar companies based on industry and business-model similarity.

EMFRET Analytics GmbH & Co. KG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH
79%
Enzyme Research Laboratories
78%
SIRION Biotech
74%

EMFRET Analytics GmbH & Co. KG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMar 30, 2026

EMFRET Analytics GmbH & Co. KG Filings

Explore SEC and related filing metadata, where available.

EMFRET Analytics GmbH & Co. KG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EMFRET Analytics GmbH & Co. KG's valuation, stock price, and market status.

Is EMFRET Analytics GmbH & Co. KG a public or private company?

EMFRET Analytics GmbH & Co. KG is a private company.

What is the current stock price of EMFRET Analytics GmbH & Co. KG?

EMFRET Analytics GmbH & Co. KG is a private company with no public stock price. Caplight tracks EMFRET Analytics GmbH & Co. KG's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is EMFRET Analytics GmbH & Co. KG worth (valuation)?

Valuation information for EMFRET Analytics GmbH & Co. KG is not publicly available.

Can I buy EMFRET Analytics GmbH & Co. KG stock?

EMFRET Analytics GmbH & Co. KG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EMFRET Analytics GmbH & Co. KG's last funding round?

EMFRET Analytics GmbH & Co. KG's most recent funding round was Corporate Funding on March 30, 2026.

Who are the main investors in EMFRET Analytics GmbH & Co. KG?

Investor information for EMFRET Analytics GmbH & Co. KG is not publicly disclosed.

Will EMFRET Analytics GmbH & Co. KG IPO soon?

No public IPO plans have been announced for EMFRET Analytics GmbH & Co. KG.

How can I track EMFRET Analytics GmbH & Co. KG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EMFRET Analytics GmbH & Co. KG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEibelstadt
Year Founded2002
Last FundingMar 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?